HUMAN MONOCLONAL ANTIBODY TO HUMAN CD134 (OX40) AND METHODS OF CREATING AND USING THE SAME

CY1125925T1Undetermined Publication Date: 2026-04-17KYOWA HAKKO KIRIN CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
CY20231100171T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2005-11-25
Filing Date
2023-03-29
Publication Date
2026-04-17
Estimated Expiration
2043-03-29
Patent Text Reader

Abstract

The invention provides antibodies that specifically bind to OX40 (CD 134), referred to as OX40 antibodies, anti-OX40 or anti-OX40 antibodies. The antibodies of the invention that specifically bind to OX40 include mammalian (human, primate, etc.), humanized and chimeric anti-OX40 antibodies. The antibodies and antibody subsequences (fragments) of the invention that specifically bind to OX40 include purified and isolated antibodies, as well as pharmaceutical compositions thereof, are useful in a variety of methods including methods of treatment, screening and detection.
Need to check novelty before this filing date? Find Prior Art